title: Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients.
authors.affiliation: Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania, USA.
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: J
authors.initials: J
authors.lastname: Reyes
authors.forename: R
authors.initials: R
authors.lastname: Kashyap
authors.forename: S
authors.initials: S
authors.lastname: Rohal
authors.forename: T
authors.initials: T
authors.lastname: Cacclarelli
authors.forename: J
authors.initials: J
authors.lastname: McMichael
authors.forename: J
authors.initials: J
authors.lastname: Rakela
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D011183:Postoperative Complications / Q000453:epidemiology*; D011241:Prednisone / Q000627:therapeutic use; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D003404:Creatinine; D011241:Prednisone; D016559:Tacrolimus